GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OSTO:BIOG B) » Definitions » Net Margin %

BioGaia AB (OSTO:BIOG B) Net Margin % : 12.04% (As of Sep. 2024)


View and export this data going back to 1998. Start your Free Trial

What is BioGaia AB Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. BioGaia AB's Net Income for the three months ended in Sep. 2024 was kr37 Mil. BioGaia AB's Revenue for the three months ended in Sep. 2024 was kr304 Mil. Therefore, BioGaia AB's net margin for the quarter that ended in Sep. 2024 was 12.04%.

The historical rank and industry rank for BioGaia AB's Net Margin % or its related term are showing as below:

OSTO:BIOG B' s Net Margin % Range Over the Past 10 Years
Min: 24.06   Med: 28.58   Max: 42.56
Current: 24.85


OSTO:BIOG B's Net Margin % is ranked better than
92.66% of 995 companies
in the Drug Manufacturers industry
Industry Median: 3.96 vs OSTO:BIOG B: 24.85

BioGaia AB Net Margin % Historical Data

The historical data trend for BioGaia AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Net Margin % Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.38 24.06 25.00 33.86 28.18

BioGaia AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.95 22.62 32.95 28.90 12.04

Competitive Comparison of BioGaia AB's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Net Margin % falls into.



BioGaia AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

BioGaia AB's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=365.352/1296.505
=28.18 %

BioGaia AB's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=36.602/303.971
=12.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioGaia AB  (OSTO:BIOG B) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


BioGaia AB Net Margin % Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB Business Description

Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB Headlines

No Headlines